<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE LCTL_TEXT SYSTEM "ltf.v1.5.dtd">
<LCTL_TEXT lang="spa">
<DOC id="L0C04CVJR" lang="spa" tokenization="tokenization_parameters.v5.0" grammar="none" raw_text_char_length="1322" raw_text_md5="8d24101360d03f73044c68afe3a6a016">
<TEXT>
<SEG id="segment-0" start_char="1" end_char="55">
<ORIGINAL_TEXT>Lopinavir/ritonavir no reduce la mortalidad en COVID-19</ORIGINAL_TEXT>
<TOKEN id="token-0-0" pos="unknown" morph="none" start_char="1" end_char="19">Lopinavir/ritonavir</TOKEN>
<TOKEN id="token-0-1" pos="word" morph="none" start_char="21" end_char="22">no</TOKEN>
<TOKEN id="token-0-2" pos="word" morph="none" start_char="24" end_char="29">reduce</TOKEN>
<TOKEN id="token-0-3" pos="word" morph="none" start_char="31" end_char="32">la</TOKEN>
<TOKEN id="token-0-4" pos="word" morph="none" start_char="34" end_char="43">mortalidad</TOKEN>
<TOKEN id="token-0-5" pos="word" morph="none" start_char="45" end_char="46">en</TOKEN>
<TOKEN id="token-0-6" pos="unknown" morph="none" start_char="48" end_char="55">COVID-19</TOKEN>
</SEG>
<SEG id="segment-1" start_char="59" end_char="230">
<ORIGINAL_TEXT>El Servicio de Medicina Interna del Hospital 12 de Octubre ha publicado, en colaboración con los servicios de interna de otros centros hospitalarios españoles, una carta en</ORIGINAL_TEXT>
<TOKEN id="token-1-0" pos="word" morph="none" start_char="59" end_char="60">El</TOKEN>
<TOKEN id="token-1-1" pos="word" morph="none" start_char="62" end_char="69">Servicio</TOKEN>
<TOKEN id="token-1-2" pos="word" morph="none" start_char="71" end_char="72">de</TOKEN>
<TOKEN id="token-1-3" pos="word" morph="none" start_char="74" end_char="81">Medicina</TOKEN>
<TOKEN id="token-1-4" pos="word" morph="none" start_char="83" end_char="89">Interna</TOKEN>
<TOKEN id="token-1-5" pos="word" morph="none" start_char="91" end_char="93">del</TOKEN>
<TOKEN id="token-1-6" pos="word" morph="none" start_char="95" end_char="102">Hospital</TOKEN>
<TOKEN id="token-1-7" pos="word" morph="none" start_char="104" end_char="105">12</TOKEN>
<TOKEN id="token-1-8" pos="word" morph="none" start_char="107" end_char="108">de</TOKEN>
<TOKEN id="token-1-9" pos="word" morph="none" start_char="110" end_char="116">Octubre</TOKEN>
<TOKEN id="token-1-10" pos="word" morph="none" start_char="118" end_char="119">ha</TOKEN>
<TOKEN id="token-1-11" pos="word" morph="none" start_char="121" end_char="129">publicado</TOKEN>
<TOKEN id="token-1-12" pos="punct" morph="none" start_char="130" end_char="130">,</TOKEN>
<TOKEN id="token-1-13" pos="word" morph="none" start_char="132" end_char="133">en</TOKEN>
<TOKEN id="token-1-14" pos="word" morph="none" start_char="135" end_char="146">colaboración</TOKEN>
<TOKEN id="token-1-15" pos="word" morph="none" start_char="148" end_char="150">con</TOKEN>
<TOKEN id="token-1-16" pos="word" morph="none" start_char="152" end_char="154">los</TOKEN>
<TOKEN id="token-1-17" pos="word" morph="none" start_char="156" end_char="164">servicios</TOKEN>
<TOKEN id="token-1-18" pos="word" morph="none" start_char="166" end_char="167">de</TOKEN>
<TOKEN id="token-1-19" pos="word" morph="none" start_char="169" end_char="175">interna</TOKEN>
<TOKEN id="token-1-20" pos="word" morph="none" start_char="177" end_char="178">de</TOKEN>
<TOKEN id="token-1-21" pos="word" morph="none" start_char="180" end_char="184">otros</TOKEN>
<TOKEN id="token-1-22" pos="word" morph="none" start_char="186" end_char="192">centros</TOKEN>
<TOKEN id="token-1-23" pos="word" morph="none" start_char="194" end_char="206">hospitalarios</TOKEN>
<TOKEN id="token-1-24" pos="word" morph="none" start_char="208" end_char="216">españoles</TOKEN>
<TOKEN id="token-1-25" pos="punct" morph="none" start_char="217" end_char="217">,</TOKEN>
<TOKEN id="token-1-26" pos="word" morph="none" start_char="219" end_char="221">una</TOKEN>
<TOKEN id="token-1-27" pos="word" morph="none" start_char="223" end_char="227">carta</TOKEN>
<TOKEN id="token-1-28" pos="word" morph="none" start_char="229" end_char="230">en</TOKEN>
</SEG>
<SEG id="segment-2" start_char="233" end_char="256">
<ORIGINAL_TEXT>The Journal of Infection</ORIGINAL_TEXT>
<TOKEN id="token-2-0" pos="word" morph="none" start_char="233" end_char="235">The</TOKEN>
<TOKEN id="token-2-1" pos="word" morph="none" start_char="237" end_char="243">Journal</TOKEN>
<TOKEN id="token-2-2" pos="word" morph="none" start_char="245" end_char="246">of</TOKEN>
<TOKEN id="token-2-3" pos="word" morph="none" start_char="248" end_char="256">Infection</TOKEN>
</SEG>
<SEG id="segment-3" start_char="259" end_char="275">
<ORIGINAL_TEXT>acerca del uso de</ORIGINAL_TEXT>
<TOKEN id="token-3-0" pos="word" morph="none" start_char="259" end_char="264">acerca</TOKEN>
<TOKEN id="token-3-1" pos="word" morph="none" start_char="266" end_char="268">del</TOKEN>
<TOKEN id="token-3-2" pos="word" morph="none" start_char="270" end_char="272">uso</TOKEN>
<TOKEN id="token-3-3" pos="word" morph="none" start_char="274" end_char="275">de</TOKEN>
</SEG>
<SEG id="segment-4" start_char="279" end_char="357">
<ORIGINAL_TEXT>lopinavir/ritonavir y sus posibles beneficios en el tratamiento de la COVID-19.</ORIGINAL_TEXT>
<TOKEN id="token-4-0" pos="unknown" morph="none" start_char="279" end_char="297">lopinavir/ritonavir</TOKEN>
<TOKEN id="token-4-1" pos="word" morph="none" start_char="299" end_char="299">y</TOKEN>
<TOKEN id="token-4-2" pos="word" morph="none" start_char="301" end_char="303">sus</TOKEN>
<TOKEN id="token-4-3" pos="word" morph="none" start_char="305" end_char="312">posibles</TOKEN>
<TOKEN id="token-4-4" pos="word" morph="none" start_char="314" end_char="323">beneficios</TOKEN>
<TOKEN id="token-4-5" pos="word" morph="none" start_char="325" end_char="326">en</TOKEN>
<TOKEN id="token-4-6" pos="word" morph="none" start_char="328" end_char="329">el</TOKEN>
<TOKEN id="token-4-7" pos="word" morph="none" start_char="331" end_char="341">tratamiento</TOKEN>
<TOKEN id="token-4-8" pos="word" morph="none" start_char="343" end_char="344">de</TOKEN>
<TOKEN id="token-4-9" pos="word" morph="none" start_char="346" end_char="347">la</TOKEN>
<TOKEN id="token-4-10" pos="unknown" morph="none" start_char="349" end_char="356">COVID-19</TOKEN>
<TOKEN id="token-4-11" pos="punct" morph="none" start_char="357" end_char="357">.</TOKEN>
</SEG>
<SEG id="segment-5" start_char="360" end_char="538">
<ORIGINAL_TEXT>El lopinavir/ritonavir se utilizó en los primeros momentos de la pandemia por su eficacia en el tratamiento del VIH, pero sin que hubiera una evidencia consistente de su eficacia.</ORIGINAL_TEXT>
<TOKEN id="token-5-0" pos="word" morph="none" start_char="360" end_char="361">El</TOKEN>
<TOKEN id="token-5-1" pos="unknown" morph="none" start_char="363" end_char="381">lopinavir/ritonavir</TOKEN>
<TOKEN id="token-5-2" pos="word" morph="none" start_char="383" end_char="384">se</TOKEN>
<TOKEN id="token-5-3" pos="word" morph="none" start_char="386" end_char="392">utilizó</TOKEN>
<TOKEN id="token-5-4" pos="word" morph="none" start_char="394" end_char="395">en</TOKEN>
<TOKEN id="token-5-5" pos="word" morph="none" start_char="397" end_char="399">los</TOKEN>
<TOKEN id="token-5-6" pos="word" morph="none" start_char="401" end_char="408">primeros</TOKEN>
<TOKEN id="token-5-7" pos="word" morph="none" start_char="410" end_char="417">momentos</TOKEN>
<TOKEN id="token-5-8" pos="word" morph="none" start_char="419" end_char="420">de</TOKEN>
<TOKEN id="token-5-9" pos="word" morph="none" start_char="422" end_char="423">la</TOKEN>
<TOKEN id="token-5-10" pos="word" morph="none" start_char="425" end_char="432">pandemia</TOKEN>
<TOKEN id="token-5-11" pos="word" morph="none" start_char="434" end_char="436">por</TOKEN>
<TOKEN id="token-5-12" pos="word" morph="none" start_char="438" end_char="439">su</TOKEN>
<TOKEN id="token-5-13" pos="word" morph="none" start_char="441" end_char="448">eficacia</TOKEN>
<TOKEN id="token-5-14" pos="word" morph="none" start_char="450" end_char="451">en</TOKEN>
<TOKEN id="token-5-15" pos="word" morph="none" start_char="453" end_char="454">el</TOKEN>
<TOKEN id="token-5-16" pos="word" morph="none" start_char="456" end_char="466">tratamiento</TOKEN>
<TOKEN id="token-5-17" pos="word" morph="none" start_char="468" end_char="470">del</TOKEN>
<TOKEN id="token-5-18" pos="word" morph="none" start_char="472" end_char="474">VIH</TOKEN>
<TOKEN id="token-5-19" pos="punct" morph="none" start_char="475" end_char="475">,</TOKEN>
<TOKEN id="token-5-20" pos="word" morph="none" start_char="477" end_char="480">pero</TOKEN>
<TOKEN id="token-5-21" pos="word" morph="none" start_char="482" end_char="484">sin</TOKEN>
<TOKEN id="token-5-22" pos="word" morph="none" start_char="486" end_char="488">que</TOKEN>
<TOKEN id="token-5-23" pos="word" morph="none" start_char="490" end_char="496">hubiera</TOKEN>
<TOKEN id="token-5-24" pos="word" morph="none" start_char="498" end_char="500">una</TOKEN>
<TOKEN id="token-5-25" pos="word" morph="none" start_char="502" end_char="510">evidencia</TOKEN>
<TOKEN id="token-5-26" pos="word" morph="none" start_char="512" end_char="522">consistente</TOKEN>
<TOKEN id="token-5-27" pos="word" morph="none" start_char="524" end_char="525">de</TOKEN>
<TOKEN id="token-5-28" pos="word" morph="none" start_char="527" end_char="528">su</TOKEN>
<TOKEN id="token-5-29" pos="word" morph="none" start_char="530" end_char="537">eficacia</TOKEN>
<TOKEN id="token-5-30" pos="punct" morph="none" start_char="538" end_char="538">.</TOKEN>
</SEG>
<SEG id="segment-6" start_char="540" end_char="800">
<ORIGINAL_TEXT>Ensayos clínicos no han demostrado rotundamente ni los beneficios ni los riesgos, por lo que los investigadores de esta carta han realizado una investigación a partir de una amplia cohorte multicéntrica (Registro SEMI-COVID-19) que superaba los 8 mil pacientes.</ORIGINAL_TEXT>
<TOKEN id="token-6-0" pos="word" morph="none" start_char="540" end_char="546">Ensayos</TOKEN>
<TOKEN id="token-6-1" pos="word" morph="none" start_char="548" end_char="555">clínicos</TOKEN>
<TOKEN id="token-6-2" pos="word" morph="none" start_char="557" end_char="558">no</TOKEN>
<TOKEN id="token-6-3" pos="word" morph="none" start_char="560" end_char="562">han</TOKEN>
<TOKEN id="token-6-4" pos="word" morph="none" start_char="564" end_char="573">demostrado</TOKEN>
<TOKEN id="token-6-5" pos="word" morph="none" start_char="575" end_char="586">rotundamente</TOKEN>
<TOKEN id="token-6-6" pos="word" morph="none" start_char="588" end_char="589">ni</TOKEN>
<TOKEN id="token-6-7" pos="word" morph="none" start_char="591" end_char="593">los</TOKEN>
<TOKEN id="token-6-8" pos="word" morph="none" start_char="595" end_char="604">beneficios</TOKEN>
<TOKEN id="token-6-9" pos="word" morph="none" start_char="606" end_char="607">ni</TOKEN>
<TOKEN id="token-6-10" pos="word" morph="none" start_char="609" end_char="611">los</TOKEN>
<TOKEN id="token-6-11" pos="word" morph="none" start_char="613" end_char="619">riesgos</TOKEN>
<TOKEN id="token-6-12" pos="punct" morph="none" start_char="620" end_char="620">,</TOKEN>
<TOKEN id="token-6-13" pos="word" morph="none" start_char="622" end_char="624">por</TOKEN>
<TOKEN id="token-6-14" pos="word" morph="none" start_char="626" end_char="627">lo</TOKEN>
<TOKEN id="token-6-15" pos="word" morph="none" start_char="629" end_char="631">que</TOKEN>
<TOKEN id="token-6-16" pos="word" morph="none" start_char="633" end_char="635">los</TOKEN>
<TOKEN id="token-6-17" pos="word" morph="none" start_char="637" end_char="650">investigadores</TOKEN>
<TOKEN id="token-6-18" pos="word" morph="none" start_char="652" end_char="653">de</TOKEN>
<TOKEN id="token-6-19" pos="word" morph="none" start_char="655" end_char="658">esta</TOKEN>
<TOKEN id="token-6-20" pos="word" morph="none" start_char="660" end_char="664">carta</TOKEN>
<TOKEN id="token-6-21" pos="word" morph="none" start_char="666" end_char="668">han</TOKEN>
<TOKEN id="token-6-22" pos="word" morph="none" start_char="670" end_char="678">realizado</TOKEN>
<TOKEN id="token-6-23" pos="word" morph="none" start_char="680" end_char="682">una</TOKEN>
<TOKEN id="token-6-24" pos="word" morph="none" start_char="684" end_char="696">investigación</TOKEN>
<TOKEN id="token-6-25" pos="word" morph="none" start_char="698" end_char="698">a</TOKEN>
<TOKEN id="token-6-26" pos="word" morph="none" start_char="700" end_char="705">partir</TOKEN>
<TOKEN id="token-6-27" pos="word" morph="none" start_char="707" end_char="708">de</TOKEN>
<TOKEN id="token-6-28" pos="word" morph="none" start_char="710" end_char="712">una</TOKEN>
<TOKEN id="token-6-29" pos="word" morph="none" start_char="714" end_char="719">amplia</TOKEN>
<TOKEN id="token-6-30" pos="word" morph="none" start_char="721" end_char="727">cohorte</TOKEN>
<TOKEN id="token-6-31" pos="word" morph="none" start_char="729" end_char="741">multicéntrica</TOKEN>
<TOKEN id="token-6-32" pos="punct" morph="none" start_char="743" end_char="743">(</TOKEN>
<TOKEN id="token-6-33" pos="word" morph="none" start_char="744" end_char="751">Registro</TOKEN>
<TOKEN id="token-6-34" pos="unknown" morph="none" start_char="753" end_char="765">SEMI-COVID-19</TOKEN>
<TOKEN id="token-6-35" pos="punct" morph="none" start_char="766" end_char="766">)</TOKEN>
<TOKEN id="token-6-36" pos="word" morph="none" start_char="768" end_char="770">que</TOKEN>
<TOKEN id="token-6-37" pos="word" morph="none" start_char="772" end_char="779">superaba</TOKEN>
<TOKEN id="token-6-38" pos="word" morph="none" start_char="781" end_char="783">los</TOKEN>
<TOKEN id="token-6-39" pos="word" morph="none" start_char="785" end_char="785">8</TOKEN>
<TOKEN id="token-6-40" pos="word" morph="none" start_char="787" end_char="789">mil</TOKEN>
<TOKEN id="token-6-41" pos="word" morph="none" start_char="791" end_char="799">pacientes</TOKEN>
<TOKEN id="token-6-42" pos="punct" morph="none" start_char="800" end_char="800">.</TOKEN>
</SEG>
<SEG id="segment-7" start_char="802" end_char="896">
<ORIGINAL_TEXT>Se trata del estudio con el mayor número de pacientes que analiza este tratamiento en COVID-19.</ORIGINAL_TEXT>
<TOKEN id="token-7-0" pos="word" morph="none" start_char="802" end_char="803">Se</TOKEN>
<TOKEN id="token-7-1" pos="word" morph="none" start_char="805" end_char="809">trata</TOKEN>
<TOKEN id="token-7-2" pos="word" morph="none" start_char="811" end_char="813">del</TOKEN>
<TOKEN id="token-7-3" pos="word" morph="none" start_char="815" end_char="821">estudio</TOKEN>
<TOKEN id="token-7-4" pos="word" morph="none" start_char="823" end_char="825">con</TOKEN>
<TOKEN id="token-7-5" pos="word" morph="none" start_char="827" end_char="828">el</TOKEN>
<TOKEN id="token-7-6" pos="word" morph="none" start_char="830" end_char="834">mayor</TOKEN>
<TOKEN id="token-7-7" pos="word" morph="none" start_char="836" end_char="841">número</TOKEN>
<TOKEN id="token-7-8" pos="word" morph="none" start_char="843" end_char="844">de</TOKEN>
<TOKEN id="token-7-9" pos="word" morph="none" start_char="846" end_char="854">pacientes</TOKEN>
<TOKEN id="token-7-10" pos="word" morph="none" start_char="856" end_char="858">que</TOKEN>
<TOKEN id="token-7-11" pos="word" morph="none" start_char="860" end_char="866">analiza</TOKEN>
<TOKEN id="token-7-12" pos="word" morph="none" start_char="868" end_char="871">este</TOKEN>
<TOKEN id="token-7-13" pos="word" morph="none" start_char="873" end_char="883">tratamiento</TOKEN>
<TOKEN id="token-7-14" pos="word" morph="none" start_char="885" end_char="886">en</TOKEN>
<TOKEN id="token-7-15" pos="unknown" morph="none" start_char="888" end_char="895">COVID-19</TOKEN>
<TOKEN id="token-7-16" pos="punct" morph="none" start_char="896" end_char="896">.</TOKEN>
</SEG>
<SEG id="segment-8" start_char="898" end_char="1036">
<ORIGINAL_TEXT>Se administró tratamiento con lopinavir/ritonavir al 63% de los pacientes, por lo general los que se encontraban en condiciones más graves.</ORIGINAL_TEXT>
<TOKEN id="token-8-0" pos="word" morph="none" start_char="898" end_char="899">Se</TOKEN>
<TOKEN id="token-8-1" pos="word" morph="none" start_char="901" end_char="910">administró</TOKEN>
<TOKEN id="token-8-2" pos="word" morph="none" start_char="912" end_char="922">tratamiento</TOKEN>
<TOKEN id="token-8-3" pos="word" morph="none" start_char="924" end_char="926">con</TOKEN>
<TOKEN id="token-8-4" pos="unknown" morph="none" start_char="928" end_char="946">lopinavir/ritonavir</TOKEN>
<TOKEN id="token-8-5" pos="word" morph="none" start_char="948" end_char="949">al</TOKEN>
<TOKEN id="token-8-6" pos="word" morph="none" start_char="951" end_char="952">63</TOKEN>
<TOKEN id="token-8-7" pos="punct" morph="none" start_char="953" end_char="953">%</TOKEN>
<TOKEN id="token-8-8" pos="word" morph="none" start_char="955" end_char="956">de</TOKEN>
<TOKEN id="token-8-9" pos="word" morph="none" start_char="958" end_char="960">los</TOKEN>
<TOKEN id="token-8-10" pos="word" morph="none" start_char="962" end_char="970">pacientes</TOKEN>
<TOKEN id="token-8-11" pos="punct" morph="none" start_char="971" end_char="971">,</TOKEN>
<TOKEN id="token-8-12" pos="word" morph="none" start_char="973" end_char="975">por</TOKEN>
<TOKEN id="token-8-13" pos="word" morph="none" start_char="977" end_char="978">lo</TOKEN>
<TOKEN id="token-8-14" pos="word" morph="none" start_char="980" end_char="986">general</TOKEN>
<TOKEN id="token-8-15" pos="word" morph="none" start_char="988" end_char="990">los</TOKEN>
<TOKEN id="token-8-16" pos="word" morph="none" start_char="992" end_char="994">que</TOKEN>
<TOKEN id="token-8-17" pos="word" morph="none" start_char="996" end_char="997">se</TOKEN>
<TOKEN id="token-8-18" pos="word" morph="none" start_char="999" end_char="1009">encontraban</TOKEN>
<TOKEN id="token-8-19" pos="word" morph="none" start_char="1011" end_char="1012">en</TOKEN>
<TOKEN id="token-8-20" pos="word" morph="none" start_char="1014" end_char="1024">condiciones</TOKEN>
<TOKEN id="token-8-21" pos="word" morph="none" start_char="1026" end_char="1028">más</TOKEN>
<TOKEN id="token-8-22" pos="word" morph="none" start_char="1030" end_char="1035">graves</TOKEN>
<TOKEN id="token-8-23" pos="punct" morph="none" start_char="1036" end_char="1036">.</TOKEN>
</SEG>
<SEG id="segment-9" start_char="1038" end_char="1293">
<ORIGINAL_TEXT>Una de sus principales conclusiones es que su uso no puede asociarse con una reducción de la mortalidad, ni tampoco su temprana utilización (mediana de 5 días) ha mostrado significativos beneficios, por lo que se desaconseja su uso frente a esta patología.</ORIGINAL_TEXT>
<TOKEN id="token-9-0" pos="word" morph="none" start_char="1038" end_char="1040">Una</TOKEN>
<TOKEN id="token-9-1" pos="word" morph="none" start_char="1042" end_char="1043">de</TOKEN>
<TOKEN id="token-9-2" pos="word" morph="none" start_char="1045" end_char="1047">sus</TOKEN>
<TOKEN id="token-9-3" pos="word" morph="none" start_char="1049" end_char="1059">principales</TOKEN>
<TOKEN id="token-9-4" pos="word" morph="none" start_char="1061" end_char="1072">conclusiones</TOKEN>
<TOKEN id="token-9-5" pos="word" morph="none" start_char="1074" end_char="1075">es</TOKEN>
<TOKEN id="token-9-6" pos="word" morph="none" start_char="1077" end_char="1079">que</TOKEN>
<TOKEN id="token-9-7" pos="word" morph="none" start_char="1081" end_char="1082">su</TOKEN>
<TOKEN id="token-9-8" pos="word" morph="none" start_char="1084" end_char="1086">uso</TOKEN>
<TOKEN id="token-9-9" pos="word" morph="none" start_char="1088" end_char="1089">no</TOKEN>
<TOKEN id="token-9-10" pos="word" morph="none" start_char="1091" end_char="1095">puede</TOKEN>
<TOKEN id="token-9-11" pos="word" morph="none" start_char="1097" end_char="1105">asociarse</TOKEN>
<TOKEN id="token-9-12" pos="word" morph="none" start_char="1107" end_char="1109">con</TOKEN>
<TOKEN id="token-9-13" pos="word" morph="none" start_char="1111" end_char="1113">una</TOKEN>
<TOKEN id="token-9-14" pos="word" morph="none" start_char="1115" end_char="1123">reducción</TOKEN>
<TOKEN id="token-9-15" pos="word" morph="none" start_char="1125" end_char="1126">de</TOKEN>
<TOKEN id="token-9-16" pos="word" morph="none" start_char="1128" end_char="1129">la</TOKEN>
<TOKEN id="token-9-17" pos="word" morph="none" start_char="1131" end_char="1140">mortalidad</TOKEN>
<TOKEN id="token-9-18" pos="punct" morph="none" start_char="1141" end_char="1141">,</TOKEN>
<TOKEN id="token-9-19" pos="word" morph="none" start_char="1143" end_char="1144">ni</TOKEN>
<TOKEN id="token-9-20" pos="word" morph="none" start_char="1146" end_char="1152">tampoco</TOKEN>
<TOKEN id="token-9-21" pos="word" morph="none" start_char="1154" end_char="1155">su</TOKEN>
<TOKEN id="token-9-22" pos="word" morph="none" start_char="1157" end_char="1164">temprana</TOKEN>
<TOKEN id="token-9-23" pos="word" morph="none" start_char="1166" end_char="1176">utilización</TOKEN>
<TOKEN id="token-9-24" pos="punct" morph="none" start_char="1178" end_char="1178">(</TOKEN>
<TOKEN id="token-9-25" pos="word" morph="none" start_char="1179" end_char="1185">mediana</TOKEN>
<TOKEN id="token-9-26" pos="word" morph="none" start_char="1187" end_char="1188">de</TOKEN>
<TOKEN id="token-9-27" pos="word" morph="none" start_char="1190" end_char="1190">5</TOKEN>
<TOKEN id="token-9-28" pos="word" morph="none" start_char="1192" end_char="1195">días</TOKEN>
<TOKEN id="token-9-29" pos="punct" morph="none" start_char="1196" end_char="1196">)</TOKEN>
<TOKEN id="token-9-30" pos="word" morph="none" start_char="1198" end_char="1199">ha</TOKEN>
<TOKEN id="token-9-31" pos="word" morph="none" start_char="1201" end_char="1208">mostrado</TOKEN>
<TOKEN id="token-9-32" pos="word" morph="none" start_char="1210" end_char="1223">significativos</TOKEN>
<TOKEN id="token-9-33" pos="word" morph="none" start_char="1225" end_char="1234">beneficios</TOKEN>
<TOKEN id="token-9-34" pos="punct" morph="none" start_char="1235" end_char="1235">,</TOKEN>
<TOKEN id="token-9-35" pos="word" morph="none" start_char="1237" end_char="1239">por</TOKEN>
<TOKEN id="token-9-36" pos="word" morph="none" start_char="1241" end_char="1242">lo</TOKEN>
<TOKEN id="token-9-37" pos="word" morph="none" start_char="1244" end_char="1246">que</TOKEN>
<TOKEN id="token-9-38" pos="word" morph="none" start_char="1248" end_char="1249">se</TOKEN>
<TOKEN id="token-9-39" pos="word" morph="none" start_char="1251" end_char="1261">desaconseja</TOKEN>
<TOKEN id="token-9-40" pos="word" morph="none" start_char="1263" end_char="1264">su</TOKEN>
<TOKEN id="token-9-41" pos="word" morph="none" start_char="1266" end_char="1268">uso</TOKEN>
<TOKEN id="token-9-42" pos="word" morph="none" start_char="1270" end_char="1275">frente</TOKEN>
<TOKEN id="token-9-43" pos="word" morph="none" start_char="1277" end_char="1277">a</TOKEN>
<TOKEN id="token-9-44" pos="word" morph="none" start_char="1279" end_char="1282">esta</TOKEN>
<TOKEN id="token-9-45" pos="word" morph="none" start_char="1284" end_char="1292">patología</TOKEN>
<TOKEN id="token-9-46" pos="punct" morph="none" start_char="1293" end_char="1293">.</TOKEN>
</SEG>
<SEG id="segment-10" start_char="1296" end_char="1317">
<ORIGINAL_TEXT>Equipo Biblioteca H12O</ORIGINAL_TEXT>
<TOKEN id="token-10-0" pos="word" morph="none" start_char="1296" end_char="1301">Equipo</TOKEN>
<TOKEN id="token-10-1" pos="word" morph="none" start_char="1303" end_char="1312">Biblioteca</TOKEN>
<TOKEN id="token-10-2" pos="word" morph="none" start_char="1314" end_char="1317">H12O</TOKEN>
</SEG>
</TEXT>
</DOC>
</LCTL_TEXT>
